ATLANTA – A Phase III clinical trial at Emory University and 42 other U.S. sites has determined that a vitamin and steroid combination given to critically ill patients with sepsis did not improve recovery, organ failure or death, when compared to a placebo. The findings of the clinical trial, which ended early, were published today in the Journal of the American Medical Association (JAMA).
/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.